S029 Treating Severe Skin Diseases in Children
DESCRIPTION
During this session, attendees will review challenging topics faced in the pediatric population. Speakers will provide updates in the diagnosis and management of several inflammatory and autoimmune conditions in children. Learners will review an approach to challenging pediatric pigmented lesions. Speakers will answer audience questions during hourly Q&As.
LEARNING OBJECTIVES
Diagnose inherited, inflammatory, infectious and autoimmune dermatologic diseases in children.
Select systemic, topical and other therapies for severe skin disease in children.
Develop an approach to managing children with severe skin disease.
SCHEDULE
9:00 AM
Updates on Management of Juvenile Dermatomyositis
Leslie Castelo-Soccio, MD, PhD, FAAD
9:25 AM
Managing Hair Loss in Children
Brittany Craiglow, MD, FAAD
9:50 AM
Q&A Drs. Castelo-Soccio and Craiglow
Leslie Castelo-Soccio, MD, PhD, FAAD, Brittany Craiglow, MD, FAAD
10:00 AM
Updates on Management of Immunobullous Diseases in Children
Raegan D. Hunt, MD, PhD, FAAD
10:25 AM
Management of Melanoma and Spitzoid Melanocytomas in Children
Elena B. Hawryluk, MD, PhD, FAAD
10:50 AM
Q&A Drs. Hawryluk and Hunt
Elena B. Hawryluk, MD, PhD, FAAD, Raegan D. Hunt, MD, PhD, FAAD
11:00 AM
Update on Management of Pediatric Hidradenitis Suppurativa
Cathryn Joy Sibbald, MD, FAAD
11:25 AM
Systemic Treatment of Pediatric Psoriasis: 5 Key Concepts
Kelly M. Cordoro, MD, FAAD
11:50 AM
Q&A Drs. Sibbald and Cordoro
Kelly M. Cordoro, MD, FAAD, Cathryn Joy Sibbald, MD, FAAD
DIRECTOR
Christine T Lauren, MD, FAAD
SPEAKERS
Leslie Castelo-Soccio, MD, PhD, FAAD
Kelly M. Cordoro, MD, FAAD
Brittany Craiglow, MD, FAAD
Elena B. Hawryluk, MD, PhD, FAAD
Raegan D. Hunt, MD, PhD, FAAD
Cathryn Joy Sibbald, MD, FAAD
DISCLOSURES
Leslie Castelo-Soccio, MD, PhD, FAAD
No financial relationships exist with ineligible companies.
Kelly M. Cordoro, MD, FAAD
No financial relationships exist with ineligible companies.
Brittany Craiglow, MD, FAAD
AbbVie – Consultant (1099 relationship)(Fees), Speaker(Honoraria); Arcutis Biotherapeutics – Consultant (1099 relationship)(Fees), Speaker(Fees); BiologicsMD, Inc. – Consultant (1099 relationship)(Fees); Concert Pharmaceuticals – Consultant(Grants/Research Funding); CorEvitas – Consultant (1099 relationship)(Fees); Dermavant Sciences, Inc. – Advisory Board(Fees); Eli Lilly and Company – Advisory Board(Fees), Consultant(Fees), Speaker(Honoraria); GlaxoSmithKline Immunology – Consultant (1099 relationship)(Fees); Incyte – Advisory Board(Fees); Incyte Corporation – Speaker(Honoraria); Leo Pharma – Advisory Board(Fees); Novartis – Advisory Board(Fees); Pfizer Inc. – Advisory Board(Fees), Consultant(Fees), Investigator(No Compensation Received), Speaker(Honoraria); Regeneron Pharmaceuticals, Inc. – Advisory Board(Fees), Consultant (1099 relationship)(Fees), Speaker(Honoraria); Sanofi Genzyme – Speaker(Honoraria); Sun Pharmaceutical Industries Ltd. – Advisory Board(Fees); Takeda Pharmaceuticals USA Inc – Advisory Board(Fees);
Elena B. Hawryluk, MD, PhD, FAAD
Apogee Therapeutics – Advisory Board(Honoraria); UpToDate, Inc – Other(Other Financial Benefit);
Raegan D. Hunt, MD, PhD, FAAD
Chiesi Farmaceutici – Advisory Board(Fees); Disc Medicine – Advisory Board(Fees); GlycosBio, Inc – Advisory Board(Stock Options), Stockholder Private Company(Stock); LEO Laboratories Ltd (LEO Pharma) – Advisory Board(Fees); Palvella Therapeutics – Investigator(Fees); Pfizer Inc. – Advisory Board(Fees); Rhythm Pharmaceuticals, Inc. – Investigator(Fees); Timber Pharmaceuticals – Data Safety Monitoring Board(Fees); UpToDate, Inc – Other(Honoraria);
Christine T Lauren, MD, FAAD
No financial relationships exist with ineligible companies.
Cathryn Joy Sibbald, MD, FAAD
AbbVie – Speaker(Honoraria); Incyte – Advisory Board(Honoraria); LEO Laboratories Ltd (LEO Pharma) – Advisory Board(Honoraria); Miravo – Advisory Board(Honoraria); Novartis – Speaker(Honoraria); Pfizer Inc. – Advisory Board(Honoraria), Speaker(Honoraria); Sanofi Genzyme – Advisory Board(Honoraria), Speaker(Honoraria); UCB – Speaker(Honoraria);